Literature DB >> 21167857

Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences.

Anthony Laugeray1, Jean-Marie Launay, Jacques Callebert, Alexandre Surget, Catherine Belzung, Pascal R Barone.   

Abstract

We previously reported that confronting mice to the Unpredictable Chronic Mild Stress procedure (UCMS) resulted in peripheral and cerebral alterations of the kynurenine pathway (KP). The present study tested whether KP disturbances are associated with differences in anxiety- and depressive-like behaviors in both naïve and UCMS mice. Non-stressed and UCMS mice were subjected to the elevated plus maze test and to the forced swim test. Mice were then sacrificed for quantification of tryptophan (TRP)-serotonin (5-HT) and TRP-kynurenine (KYN) metabolites in two corticolimbic structures involved in the regulation of mood (cingulate cortex=CC; amygdala=AMY). We showed that an elevated peripheral (lung) KYN/TRP ratio is correlated to the magnitude of anxiodepressive-like phenotypes only in UCMS mice. We also observed, in UCMS mice, that a high peripheral (lung) KYN/TRP ratio is associated with an increased metabolism of 5-HT in CC and a reduced level of kynurenic acid (KYNA) in AMY. Our results suggest that elevated peripheral KP might underlie cerebral biochemical changes and might consequently be involved in the modulation of behavior but only in UCMS mice. These findings make more complete the comprehension of the KP involvement in behavioral changes induced by chronic stress and suggest that it could play a crucial role in the modulation of emotional states.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167857     DOI: 10.1016/j.pbb.2010.12.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

Review 1.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.

Authors:  Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo
Journal:  J Psychiatr Res       Date:  2015-05-19       Impact factor: 4.791

2.  NextGen Brain Microdialysis: Applying Modern Metabolomics Technology to the Analysis of Extracellular Fluid in the Central Nervous System.

Authors:  Chi-Ya Kao; Elmira Anderzhanova; John M Asara; Carsten T Wotjak; Christoph W Turck
Journal:  Mol Neuropsychiatry       Date:  2015-04-29

3.  Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

Authors:  M Elizabeth Sublette; Hanga C Galfalvy; Dietmar Fuchs; Manana Lapidus; Michael F Grunebaum; Maria A Oquendo; J John Mann; Teodor T Postolache
Journal:  Brain Behav Immun       Date:  2011-05-14       Impact factor: 7.217

Review 4.  Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge.

Authors:  Alexander Salazar; Bryan L Gonzalez-Rivera; Laney Redus; Jennifer M Parrott; Jason C O'Connor
Journal:  Horm Behav       Date:  2012-03-31       Impact factor: 3.587

Review 5.  Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

Authors:  Nikhil Neelkantan; Alina Mikhaylova; Adam Michael Stewart; Raymond Arnold; Visar Gjeloshi; Divya Kondaveeti; Manoj K Poudel; Allan V Kalueff
Journal:  ACS Chem Neurosci       Date:  2013-08-06       Impact factor: 4.418

6.  Branched-chain amino acids alter neurobehavioral function in rats.

Authors:  Anna Coppola; Brett R Wenner; Olga Ilkayeva; Robert D Stevens; Mauro Maggioni; Theodore A Slotkin; Edward D Levin; Christopher B Newgard
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-18       Impact factor: 4.310

Review 7.  Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins.

Authors:  George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-10-02       Impact factor: 5.590

8.  Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.

Authors:  Jonathan Savitz; Wayne C Drevets; Chelsey M Smith; Teresa A Victor; Brent E Wurfel; Patrick S F Bellgowan; Jerzy Bodurka; T Kent Teague; Robert Dantzer
Journal:  Neuropsychopharmacology       Date:  2014-07-30       Impact factor: 7.853

9.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

10.  Postpartum depression: psychoneuroimmunological underpinnings and treatment.

Authors:  George Anderson; Michael Maes
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.